Divalproex Sodium Capsule, Coated Pellets
Product Images NDC 70756-447

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 70756-447). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lifestar Pharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (6f313124 D14c 4a2f Bd59 94ffbcc0b86a 187 2)

Close-up image of a white capsule imprinted with 'LS' above the number '447'. This capsule corresponds to divalproex sodium 125 mg, coated pellets for oral use, manufactured by Lifestar Pharma LLC, matching product NDC 70756-447.*

FDA Label Image

Image (6f313124 D14c 4a2f Bd59 94ffbcc0b86a 187 3)

The image shows a white capsule with coated pellets labeled 'LS 447.' The capsule corresponds to divalproex sodium 125 mg strength. The labeler is Lifestar Pharma LLC.*

FDA Label Image

Image (6f313124 D14c 4a2f Bd59 94ffbcc0b86a 187 4)

Illustration showing a hand pouring small coated pellets from a capsule marked with 'LS' into a container or onto a surface. The image relates to divalproex sodium capsules containing coated pellets for oral use, highlighting the pellet formulation.*

FDA Label Image

Image (6f313124 D14c 4a2f Bd59 94ffbcc0b86a 187 5)

An instructional illustration showing a person being administered oral medication from a spoon held by another hand. The image likely demonstrates proper oral dosing technique.*

FDA Label Image

Structure (919cc072 Ce45 417d 9ce5 7074d4c0b2d2 01)

Chemical structure diagram of divalproex sodium, showing the atomic and molecular arrangement including sodium (Na) ions and organic groups characteristic of the compound.*

FDA Label Image

Figure (919cc072 Ce45 417d 9ce5 7074d4c0b2d2 02)

A line graph titled Figure 1 showing percentage reduction in CPS rate versus percentage of patients. Two lines compare Divalproex sodium (solid line) and Placebo (dashed line), illustrating patients' improvement or worsening. The vertical axis ranges from -100% to 100% reduction in CPS rate, with labels indicating Improvement, No Change, and Worsening. The horizontal axis shows percentage of patients from 100 to 0.*

FDA Label Image

Figure2 (919cc072 Ce45 417d 9ce5 7074d4c0b2d2 03)

A line graph showing percentage reduction in CPS rate on the vertical axis with improvement and worsening indicated, and percentage of patients on the horizontal axis. Two lines compare high dose (solid line) and low dose (dashed line) of divalproex sodium, illustrating patient response across different dose levels.*

FDA Label Image

Divalproex-125mg (919cc072 Ce45 417d 9ce5 7074d4c0b2d2 04)

Label for Lifestar Pharma LLC's divalproex sodium delayed-release capsules, USP, 125 mg strength. The image shows the front and side panels including dosage form as coated pellets in capsule form, quantity of 30 capsules, and storage instructions. The label notes valproic acid activity, medication guide availability, and container instructions. Product is manufactured in Taiwan and includes a QR code linking to medication guides.*

FDA Label Image

100's Pack (919cc072 Ce45 417d 9ce5 7074d4c0b2d2 05)

Label for Divalproex Sodium Delayed-Release Capsules, USP 125 mg, coated pellets in capsule form. The package contains 100 capsules and is labeled by Lifestar Pharma LLC. The label includes storage instructions, a medication guide notice, and identifying markings (blue to blue transparent cap, off white to white opaque body). The product NDC is 70756-447-11.*

FDA Label Image

500's Pack (919cc072 Ce45 417d 9ce5 7074d4c0b2d2 06)

Label for Divalproex Sodium Delayed-Release Capsules, USP 125 mg by Lifestar Pharma LLC. The label indicates 500 capsules per container, with capsules described as light blue to blue transparent cap and white opaque body. The label includes storage instructions, medication guide dispensing information, manufacturer address in Mahwah, NJ, and a barcode with QR code for additional drug information.*

FDA Label Image

1000's Pack (919cc072 Ce45 417d 9ce5 7074d4c0b2d2 07)

Label for Divalproex Sodium Delayed-Release Capsules, USP 125 mg by Lifestar Pharma LLC. The label indicates the capsules contain valproic acid activity 125 mg, packaged as 1000 capsules. Instructions highlight storing conditions, capsule appearance, and caution to keep out of reach of children. The product is manufactured in Taiwan with an NDC of 70756-447.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.